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1. Introduction 
 
Providing computerized decision support for clinical decisions can be seen as a challenging task. 
Systems need to integrate and interpret large amounts of clinical data, providing rational advice 
that can be easily understood. In addition, systems need to be easily maintained and transferable 
between clinical institutions where the prevalence of disease or the culture of treatment may be 
quite different. 
Approaches for providing computerized decision support range from: focusing on data, i.e.  
building statistical models to describe measurements; modeling the physiological and 
pathophysiological processes; to building systems representing the heuristic reasoning of 
clinicians, often structured as sets of rules. In the intensive Care unit, and in particular in the 
control of mechanical ventilation, representation of heuristic reasoning can be seen currently as 
the most successful approach to providing decision support. This approach has produced systems 
which have both been tested in multi-center randomized control trials [1,2,3,4], and 
commercialized [1,4]. 
Each of these approaches can be seen as having contrasting advantages and disadvantages. 
Approaches based on data may be most appropriate where a large number of measurements are 
taken and little is known about physiological processes. Systems based on heuristic reasoning do 
not require a detailed understanding of physiology or large amounts of data, but suffer from the 
nature of heuristic knowledge, in that the knowledge contained in these systems implicitly 
includes that related to both physiological mechanisms and clinical preference. The lack of 
explicit, independent representation of these could be postulated as a cause of transferability 
problems, particularly in situations where clinical preference changes due to regional or cultural 
variation. 
Physiological model based systems enable separation between physiological knowledge and 
clinical preference, the latter of which being expressed using decision theory [5], in the form of 
utility functions. It can be argued that this makes such systems inherently maintainable and 
transferable, as preferences can be modified to local situations or clinical practice, with 
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physiological models remaining stable. The disadvantage of such systems can be seen as the 
relative expense of model building. Systems such as these require not only a thorough 
understanding of the physiology and pathophysiology, but also building of models which have 
the property of parsimony [6, p32]. ‘Parsimony’ in this context, relates to the necessary 
complexity of the physiological models. Models that are too simple will not adequately describe 
the patient data or produce accurate simulations. Models that are too complex are typically over-
parameterised or un-identifiable, meaning that there is not a unique set of parameter values 
which characterize the patient data, or that additional data collection is required. To effectively 
use physiological models in decision support, the balance between complexity and 
parameterization is crucial. Models both need to be tuned to the individual patient from routinely 
available data, and model parameters should be sufficient to have physiological meaning. The 
concept of building ‘minimal’ models, of separating the relevant from the irrelevant, is the ‘art’ 
of the modeling process for those working in model-based decision support. 
 It is the philosophy of the work undertaken as part of this dissertation, that building models is a 
good thing to do, for several reasons. As mentioned, from a decision support system (DSS) 
perspective they provide the natural division between physiology and preference. Perhaps 
equally as important, is that models built tend to raise interesting questions relating to our 
understanding of physiology, of how to help integrate existing measurements, and lead to new 
ideas for research, and for clinical and commercial applications. 
This dissertation describes work undertaken between 1997-2009 at the Center for Model-based 
Medical Decision Support (MMDS), Aalborg University. It describes work on the project known 
as the INtelligent VENTilator project (INVENT), the structure of which is illustrated in figure 1. 
The original, and existing, goal of this project is to build a model based DSS to suggest 
appropriate settings from mechanical ventilation of patients residing in the ICU.  To do so has 
required building several physiological models (layer 1, figure 1). These include: a model of 
pulmonary gas exchange focusing on oxygen transport and a model of the acid-base and 
oxygenation status of the blood, interstitial fluid and tissues focusing on carbon dioxide 
transport. Models require validation (layer 2, figure 1), and  studies have been performed 
comparing the model of pulmonary gas exchange against the reference technique [7]; and to 
compare the model of acid-base chemistry with literature and experimental data including the 
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mixing of blood at different gas partial pressures.   During the project period these models have 
raised interesting scientific and clinical questions (layer 3, figure 1). Answering some of these 
questions has led to the development of two further systems, the Automatic Lung Parameter 
Estimator (ALPE) system, and a system for arterialisation of venous blood (ARTY) (layer 4, 
figure 1). In turn development of these systems has led to the writing of patents, formation of 
start-up companies and product development. 
  
 
Figure 1 – The Intelligent Ventilator (INVENT) project 
 
This dissertation is structured so as to review the branches of the INVENT project illustrated in 
figure 1. Section 2 describes the modeling of pulmonary gas exchange focusing on the transport 
of oxygen. The section describes comparison of this model with the reference MIGET technique. 
In addition the section describes the ALPE system and the clinical problems addressed using 
ALPE. Section 3 describes the modeling of acid-base chemistry of the blood, and the validation 
of this model including experiments involving the mixing of blood. The section also describes 
the ARTY system and the clinical problems addressed using ARTY. Section 4 describes the 
integration of these models into the INVENT system. The discussion returns to the theme of this 
dissertation, i.e. the benefits of building models when constructing DSS systems, reflecting on 
the contribution of this work and the need for further research. 
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2. Pulmonary gas exchange 
 
2.1 Introduction. 
To simulate changes of mechanical ventilation strategy on patient state requires a model of 
pulmonary gas exchange, i.e. the exchange of oxygen and carbon dioxide between the alveolar 
gas and blood phases within the lungs. Abnormalities in pulmonary gas exchange can be due to a 
mismatch in the distribution of ventilation and perfusion in the lungs, or due to diffusion 
limitation, all of which can be described by applying only five well known equations: the 
alveolar air equation; an equation describing venous admixture; Fick’s first law of diffusion; the 
Fick principle of blood flow; and the Bohr equation for estimation of dead space [8]. The 
extremes of V/Q mismatch range from pulmonary shunt, where collapsed or edema filled alveoli 
are perfused giving a V/Q ratio of zero; to alveolar deadspace, where ventilated regions of the 
lungs are not perfused giving an infinite value for the V/Q ratio. The lungs can therefore be 
thought of as a continuum, with V/Q ratios ranging from shunt to alveolar dead space. The role 
of diffusion limitation in pulmonary gas exchange was largely settled by the development of the 
multiple inert gas elimination technique (MIGET) [7]. The use of this technique has shown in 
numerous studies, that it is possible to describe the gas exchange properties of six inert gasses 
with very different solubility in blood, plus oxygen, using only models of V/Q mismatch, as 
summarized in  [9-13]. The exceptions to this being in cases of pulmonary fibrosis [14] and 
exercise [15,16]. In general then, the conclusion that diffusion abnormalities are not the major 
cause of alveolar-arterial oxygen pressure differences has been acknowledged, even by those 
typically associated with the study of these effects [17].   
In the clinical setting, few techniques exist to appropriately assess pulmonary gas exchange in 
mechanically ventilated patients residing in the ICU. Oxygenation problems are typically only 
assessed via arterial blood gas values or the ratio of arterial oxygen partial pressure to inspiratory 
oxygen fraction (PAO2/FIO2 ratio). The PAO2/FIO2 ratio has been shown by our group [18] to be a 
poor description of oxygenation problems, varying dramatically with FIO2 levels, and causing 
misclassification of patients with acute lung injury (ALI) and acute respiratory distress syndrome 
(ARDS). 
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In the experimental setting, MIGET is the reference technique for describing pulmonary gas 
exchange [7]. In this technique six tracer gasses are infused intravenously for a period of about 
45 minutes to enable equilibrium. Simultaneous measurements are then taken of inert gas values 
in the mixed venous, arterial and mixed expired gasses, and these used to calculate the measured 
retention and excretion for each inert gas. Retention is the ratio of partial pressures of the inert 
gasses in the arterial and mixed venous blood, i.e. Pa/Pv. This varies from zero, for a gas that is 
completely excreted from the blood, to one for a gas that is completely retained. Excretion is 
similarly defined as the ratio of partial pressures in the expired and mixed venous gasses. 
Measured values of retention and excretion are then used with a compartmental model of the 
lung to calculated shunt, alveolar deadspace, and the ventilation and perfusion distributions over 
a range of pre-set V/Q values dividing the lungs into 50 compartments. The mathematical 
description of these compartments is described by the combination of only two equations: the 
Fick principle of blood flow and the alveolar air equation. These two equations for each of the 50 
compartments are linearly combined to describe the retention and excretion of each gas over the 
whole lung [7,19]. Whilst MIGET remains the reference technique for understanding pulmonary 
gas exchange its application in the clinic has been somewhat limited [20], even in its less 
invasive form [21].  
 
2.2 Mathematical modeling of oxygen transport 
Given the large discrepancy between the clinical and experimental measurement of pulmonary 
gas exchange, a large focus of this work and of the INVENT team has been to describe a 
mathematical model of gas exchange which is both physiologically sound and identifiable from 
data easily collected in the clinic. The focus of this work has been on describing oxygen 
transport, and the resulting model is illustrated in figure 2. This model is that included in the 
Automatic Lung Parameter Estimator (ALPE) system, and will therefore be referred to as the 
ALPE model. This model is a three compartment model of the lungs representing two ventilated 
and perfused compartments, and pulmonary shunt. Two parameters are used to describe V/Q 
abnormalities: shunt, i.e. the percentage of cardiac output which passes through the lung without 
being involved in gas exchange, and fA2, the fraction of ventilation to a compartment receiving 
90% of the non-shunted perfusion. Interestingly, fA2 can be used to calculate the drop in O2 
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partial pressure from the expired gas to the end capillary blood, i.e. ΔPO2, (equation 8, figure 2). 
This drop is the necessary increase in O2 partial pressure required to fully saturate the non-
shunted pulmonary blood and as such can be called the oxygen normalization pressure (ONP). If 
ONP is 10 kPa then the patient requires an FIO2 of 21%+10%= 31%. A further increase in FIO2 
only marginally increases the oxygen concentration of capillary blood by increasing O2 in 
solution. As the solubility coefficient for O2 in blood is small (0.01 (mmol/l)/kPa) this extra 
oxygen transported is small for O2 delivered at atmospheric pressure. 
The equations included in figure 2 have been described in detail previously [22]. In summary, 
the equations represent steady state conditions of oxygen transport in the whole body. Equations 
1-4 describe oxygen flow into the alveoli and blood (VO2) from each of the compartments. Eq. 5 
describes the expired oxygen fraction (FEO2) as a sum of that from alveolar compartments. Eqs. 
6 and 7 calculate the partial pressure of oxygen in the two lung capillary compartments (PcO2(1), 
PcO2(2). Equation 8 describes the calculation of ∆PO2, and equation 9 the concentration of 
oxygen in arterial blood (CaO2) by mixing the capillary compartments. Equations 10-14 describe 
the relationship between partial pressure (PO2), saturation (SO2) and concentration (CO2) of 
oxygen in the blood capillary compartments as a function of other variables in blood and the 
oxygen dissociation curve (ODC). Eqs. 15 and 16 describe the concentration of oxygen in the 
lung capillary compartments (CcO2(1), CcO2(2)) as the venous concentration (CvO2) plus the 
increase in oxygen concentration due to alveolar equilibration. Eq. 17 calculates the venous 
oxygen concentration (CvO2) as the arterial oxygen concentration (CaO2) minus the drop in 
oxygen concentration due to tissue consumption. 
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Figure 2 – The mathematical model of oxygen transport [22] (With kind permission from 
Springer Science+Business Media: Intensive Care Med., Non-invasive estimation of shunt and 
ventilation-perfusion mismatch, 29, 2003, electronic supplement, Kjærgaard S, Rees S, 
Malczynski J, Nielsen JA, Thorgaard P, Toft E, Andreassen S.) 
 
Simulations of end tidal oxygen fraction versus arterial oxygenation, performed using this model, 
illustrated in figure 3, show the physiological effects of change in shunt and ∆PO2 on 
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oxygenation. Shunt is not responsive to increases in alveolar oxygen partial pressure and as a 
result the curve shown in figure 3 for increased shunt is quite flat. Areas of the lung with low 
V/Q ratio, as characterized by fA2 or ∆PO2, are by definition responsive to changes in alveolar 
oxygenation, and as such the slope of the curve is steep. It is clear from these simulations that 
changes in FIO2 and measurement of SpO2, possible in the clinic, can be used to determine the 
degree of the two abnormalities, shunt and low V/Q ratio, as shown by our group [22] and that of 
Jones and colleagues [23].  
 
 
Figure 3 – Simulations of variation in arterial oxygenation with inspired oxygen fraction (FIO2) 
at different values of pulmonary shunt (A) and ∆PO2 (B). Reproduced, and slightly modified, 
from [18].   
 
2.3 Model Validation 
To explore whether the ALPE model has appropriate physiological complexity, it has been 
compared with the reference technique for estimating pulmonary gas exchange, i.e. the multiple 
inert gas elimination technique (MIGET) [7]. This comparison has been performed in two 
phases: first to see if the ALPE model could fit the experimental data provided by MIGET in 
health and disease, i.e. data describing the retention and excretion of inert gasses [24]; second, to 
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determine whether the models could simulate changes in arterial oxygenation seen in health and 
disease in a form comparable to MIGET [25]. A summary of these studies follows: 
 
2.3.1 Comparison of the simple model of pulmonary gas exchange with the MIGET. 
Seven pigs were anesthetized, muscle relaxed, and mechanically ventilated (volume controlled 
mode), and following infusion of MIGET tracer gasses and an equilibration period of 45 min, 
baseline measurements of hemodynamic and ventilatory parameters were taken and a 
determination of ventilation-perfusion distribution was performed using MIGET. In addition 
FIO2 levels were varied at baseline in 4-5 steps, with an equilibration period of 5 minutes 
between each step, with measurement of: ventilation volumes, inspired and end-expired oxygen, 
end-expired carbon dioxide (FEO2), mixed expired O2 and CO2 and cardiac output. Lung injury 
was subsequently induced using infusion of oleic acid.  After allowing for stabilization of the 
lung injury for 90 min, a series of determinations of ventilation-perfusion distributions were 
performed at different levels of PEEP and inspiratory-to-expiratory (I:E) ratio. Values of PEEP 
and I:E ration were selected so as to be compatible with clinical treatment of acute lung injury 
these being:  PEEP= 5, 10 and 18 cmH2O, at I:E = 1:2; and PEEP = 10 cmH2O, at I:E 2:1.  These 
series of ventilation-perfusion determinations were obtained both using the MIGET technique 
and from variation of FIO2 levels, as for baseline conditions. Thirty minutes were allowed 
between each change in PEEP and I:E ratio. 
MIGET data were used to obtain the measured retention (Rm) and excretion (Em) in the usual 
way [7].  The 50-compartment MIGET model and the ALPE model figure 2, were fitted to 
measured retention and excretion data obtained from each pig on each of the five different 
occasions. For the ALPE model values of anatomical dead-space volume (VD), pulmonary shunt 
(shunt), and fA2, were uniquely identified from retention and excretion data as described in [24]. 
For the 50-compartment MIGET model values of model parameters describing the ventilation 
and perfusion of the 50 compartments were calculated using the standard MIGET computer 
software [19]. MIGET parameters were used to calculate summary statistics describing the mean 
and log standard deviation (log SD) of the ventilation (log SDV) and perfusion (log SDQ) of the 
compartments.  
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Calculation of the parameters of both the MIGET and the ALPE model were performed by 
fitting inert gas data at a single FIO2 level. The recovered V/Q distributions of the MIGET and 
ALPE model were then used to simulate arterial oxygen partial pressure (PaO2) when FIO2 was 
varied and these values compared to measured values.  
These data were then used to answer the following questions [24,25] 
1) Can the ALPE model adequately describe MIGET data in a physiological situation 
analogous to acute lung injury, and does it give similar parameter values to the MIGET 
model? [24] 
2) Can the MIGET and simple model give accurate and comparable predictions of PaO2 
across a range of PEEP, Inspiratory : Expiratory (IE) ratio, and FIO2 settings compatible 
with clinical treatment of acute lung injury? [25] 
 
 
The results of question 1 are illustrated in table 1, taken from [24]. Table 1 gives the values of 
ALPE parameters when fitted to inert gas data, plus the weighted residual sum of squares 
(WRSS) of the fitting. The ALPE model was a good fit to the data, having an average WRSS 
equal to 9.2, not significantly different (χ
2
 test) from the expected value due to measurement 
error of 9.0. This was the case in all but 4 of the 34 cases, which represented the most severe gas 
exchange abnormalities, suggesting that at extremes of abnormality the ALPE model is not 
sufficiently complex. 
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Table 1- Values of parameters and WRSS when the simple model is fitted to inert-gas data. 
Reproduced from [24]  
Calculated values of anatomical dead space were almost identical for the MIGET and simple 
models, with a bias and standard deviation of the difference between these values equal to 0.002 
±0.002 liter. For shunt the simple model overestimated shunt by only 7%, meaning that a shunt 
value of 40.0% would be estimated as 42.8%. Values of fA2 correlated well with both log SDV 
and log SDQ, with the correlation coefficients of linear correlations between log SDV and fA2  
and  log SDQ and fA2 being r
2
 =0.92 and r
2
 =0.86, respectively.  
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Figure 4 – The comparability (fig 4A) and accuracy (fig 4B) of MIGET and simple model 
predictions of PaO2 over a clinically interesting range of PaO2 (Reproduced and modified from 
[25]) 
The results of question 2 are illustrated in figure 4, taken from [25]. Figure 4 shows that the 
simple model provides a description of arterial oxygenation at different values of FIO2 which is 
both comparable to the MIGET and accurate.  Figure 4a illustrates the comparability of 
simulations of PaO2 performed using the two models over all ventilator settings with 62 
measurements included in this plot, one for each FIO2 level at each ventilator setting , where  7 
kPa ≤PaO2 ≤ 20 kPa. This range of PaO2 was selected to be compatible with that usually seen in 
the management of acute lung injury.  The MIGET model simulates values of PaO2 on average 
0.22 kPa + 0.59(SD) higher than the ALPE model for all cases. Figure 4b illustrates the accuracy 
of simulations performed using the two models over all ventilator settings, i.e. the same 62 
measurements. The difference between model predicted and measured values of PaO2 was almost 
the same for the two models, 0.33 kPa + 1.48(SD) (MIGET model) and 0.12 kPa + 1.33(SD) 
(ALPE model). The ALPE model’s ability to compare well with MIGET and simulate PaO2 
accurately might mean that it is interchangeable with the MIGET model in a clinical setting 
where only a limited amount of data are readily accessible. 
The answer to both these research questions seems therefore positive, but some care should be 
taken when interpreting the results. Oleic acid induces a quite homogeneous lung damage, and as 
such it is possible that more complex models are required to describe heterogeneous lung 
damage such as occurs in ARDS. However, the simple model still represents a significant 
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improvement to the usual clinical standard describing oxygenation problems, i.e. using the 
PaO2/FIO2 ratio, and may therefore have application in clinical situations where the MIGET 
technique is not practical. 
 
2.4 ALPE - systems development and clinical application. 
An automated system combining the ALPE model of pulmonary gas exchange with a technique 
for varying FIO2 to achieve SpO2 over the range 90-100% has been developed [26] and is known 
as the Automated Lung Parameter Estimator (ALPE). In the research version of 2002 [26], the 
system consisted of a ventilator, a gas analyser with pulse oximeter, and a computer. The 
computer programs controlled the experimental procedure, collecting data from the ventilator 
and gas analyser, and estimating pulmonary gas exchange parameters. A Bayesian technique has 
been developed to for recursive parameter estimation during FIO2 variation [27] which can be 
used to guide the selection of appropriate FIO2 levels. Figure 4 illustrates ALPE in its research 
form from 2002, and its current commercial form ALPEessential™ as developed by Mermaid 
Care A/S. ALPE is patented [28] and ALPEessential™ is CE approved for medical use.  
The ALPE technique has been applied in a large number of patients primarily to assess whether 
it can be used to describe changes in the status of the lungs in the clinic. This question has, and 
continues to be, addressed by a series of clinical PhD projects [29, 30], and is not therefore the 
focus of this dissertation. To date, these have focused upon the post-operative effects of surgical 
interventions on gas exchange and the time course of changes thereafter [31-35]. The major 
finding of these studies, from the perspective of gas exchange, has been the peak in gas exchange 
abnormalities seen in the late post operative period, i.e. 2-3 days, consistent with the reported 
large numbers of cases of episodic night time hypoxaemia during this same period [36]. 
Studies have also been performed illustrating that ALPE can characterize gas exchange in a 
range of ICU patients [18, 22], and in those presenting at cardiology departments [37, 38]. In 
cardiology patient ALPE may be a useful tool for evaluating the degree of edema and monitoring 
the effects of therapeutic intervention in patients with left sided heart failure resulting in 
decompensation [38]. 
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Figure 4 – The Automatic Lung Parameter Estimator (ALPE) system, in its research [26], and 
commercial (ALPEessential™) forms. (The research version is printed with kind permission 
from Springer Science+Business Media: J Clin Monit Comput, The Automatic Lung Parameter 
Estimator (ALPE) system: Non-invasive estimation of pulmonary gas exchange parameters in 
10-15 minutes, 17, 2002, page 44, Rees SE, Kjærgaard S, Thorgaard P, Malczynski J, Toft E, 
Andreassen S, figure 1. The commercial picture is with kind permission of Mermaid Care A/S) 
 
2.5 Summary of chapter. 
This chapter has discussed the state of the art for describing pulmonary gas exchange in the 
clinical and experimental settings, illustrating the large difference between that understood and 
that systematically used in the clinic. A mathematical model has been developed which, in 
combination of variation in inspired oxygen fraction, can describe pulmonary gas exchange more 
accurately that current clinical techniques. This technique and model have been developed into 
research and commercial tools, and evaluated both in the clinical setting and when compared to 
the reference technique (MIGET) for experimental measurement of pulmonary gas exchange.     
 
15 
 
3.The acid-base and oxygen status of blood 
 
3.1 Introduction 
To simulate changes in mechanical ventilation strategy on patient state requires a model of the 
acid-base and oxygen status of the blood. The mathematical modeling and clinical interpretation 
of acid-base status remains an area of fierce debate in the literature. In the 1970’s, this debate 
focused around the clinical use of the mathematical models of Siggaard-Andersen [39]. In a large 
series of papers he and co-workers formulate models of acid-base chemistry which for many 
remain the basis of clinical interpretation. In short, these include the Henderson-Hasselbach 
equation, the Van Slyke equation for calculating the buffering properties of the blood [40], and a 
formulation of the oxygen dissociation curve including the Bohr-Haldane effects [41]. Graphical 
solution of these equations can be viewed as two nomograms [42,43,44], the latter of which 
provides clinical interpretation of patient state and is included in some commercial blood gas 
analysers. 
The models of Siggaard-Andersen and co-workers were criticized during the 1970’s, in what has 
become known as the Great Trans-Altantic debate [45].  This criticism was initiated by the work 
of Schwartz and co-workers [46,47] who in showing bicarbonate distribution to interstitial fluid 
illustrated the lack of agreement between the in vitro and in vivo buffering curves of blood. They 
argued therefore that base excess (BE) was unstable, and suggested that pH and bicarbonate 
(HCO3) be the primary variables used to quantify acid-base status. This led to a new formulation 
of BE in the extra-cellular fluid (ECF), by Siggaard-Andersen, a value which then remained 
stable regardless of the distribution of bicarbonate across different extra cellular fluid 
compartments. Despite this, the two schools persist and the clinical interpretation including BE 
has never readily been adopted in North America. 
In the 1980’s the literature debate changed focus somewhat following the work of Peter Stewart 
[48] which has received much focus recently [49]. Stewart formulated mathematical models for 
the acid-base chemistry of any body fluid based on strong ion theory, where link between 
electrolyte and acid-base status was explicitly modeled, through the strong ion difference (SID), 
i.e. the difference between strong cations and anions. This point was in itself not new, being 
recognized much earlier by Singer and Hastings [50]. Indeed, the Siggaard-Andersen models 
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including anion gap in its corrected form [51], can be seen as approximately mathematically 
equivalent [52]. The fact that the approaches can be considered complementary has been 
recognized by a few authors [52,53,54], and studies have been performed comparing the clinical 
use of parameters calculated using either approach [55]. However, as discussed by Matousek et 
al [52], great care should be taken when interpreting these studies to make sure that parameters 
compared from each approach are indeed comparable. Parameters such as BE and strong ion gap 
(SIG) are not, the former is a measure of buffering the latter a measure of unmeasured anions.  
The main contribution of Stewart has probably been twofold. First, he has focused attention on 
the causes of metabolic acidosis, in particular in disorders like hyperchloraemic acidosis, where 
changes in strong ion difference or buffer base can be due to electrolyte disturbances [56]. In this 
context it is important to realize that Siggaard-Andersen and co-workers never suggested that 
acid-base changes occurred in isolation of electrolytes.  Stewart has however focused the 
research community on this link, and some authors have proposed that Stewart’s approach is a 
revolution in our understanding of acid-base balance [55,56].  
The other major advantage seen in the strong ion approach concerns the simplicity, or perhaps 
transparency, of the modeling methodology adopted. Stewart formulated his model from mass 
balance and mass action equations, with sate variables describing the necessary components of 
the body fluid, e.g. for plasma, protein/phosphate (Atot), carbon dioxide (PCO2) and buffer base 
(SID). This simplicity is beneficial in that the mathematical equations are similar to the reaction 
equations, improving their understanding. In addition, the state variables have an additive 
property such that common physiological processes, like the mixing of body fluids, are easily 
simulated using conservation of mass principles. Typically, Stewart’s equations have been used 
to describe cell free fluids, e.g. cerebrospinal fluid [54,57], however more recent work has 
applied Stewart’s approach to muscle cells [58] and blood [59].   
When looking at the necessary modeling complexity required to represent acid-base and 
oxygenation transport in a ventilator management system, several requirements are clear. First, 
the models of blood should be convenient to use in a compartment modeling approach. For 
example, it should be possible to simply and accurately simulate the situation where blood 
coming from different regions of the lungs mixes before entering the arterial compartment. In 
this sense, Stewart’s mass-balance mass-action representation of plasma is a convenient 
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mathematical formulation. A second requirement is that the models be covering. This means 
representation of all the relevant components of blood, and their relation to oxygen transport and 
acid-base chemistry. This includes incorporation of modeling of the red blood cells, available 
only in the newest Stewart type models [59], and representation of Bohr-Haldane effects, i.e. the 
oxygen binding to haemoglobin or the competitive binding of oxygen, hydrogen ions and carbon 
dioxide on haemoglobin. The Bohr-Haldane effects have not previously been included in any of 
the models formulated using the Stewart approach, but have been experimentally deterimined 
and mathematically described by Siggaard-Andersen and colleagues [60, 61]. 
3.2 Mathematical models of acid-base and oxygen status.     
The approach taken here to modeling the acid-base of blood has been to formulate models with 
the approach of Stewart but the coverage of Siggaard-Andersen. In doing so Stewart’s 3 
components of extracellular fluid, in this case plasma, i.e. non-bicarbonate buffers (Atot), 
SID/BB and CO2 are extended to include the components of red blood cells, i.e. haemoglobin 
(Hb(RH)bNH3
+
), oxygen (O2) and 2,3-diphospohoglycerate (DPG). The model formulated with 
these components, as illustrated in figure 5, has been described in detail previously [62,63], a 
brief summary follows. 
For plasma, lumped bicarbonate and non-bicarbonate buffer reactions (R1r, R2r) are included. 
For the erythrocyte fraction of blood, haemoglobin is written as Hb(RH)bNH3
+
 to reflect the side 
chain (RH)b and amino end (-NH3
+
) buffering sites. Haemoglobin binding to H
+
, O2 and CO2 is 
drawn as three blocks of reaction equations A-C. Blocks  A and B represent the binding of  H
+
 to 
the amino end of the haemoglobin molecules protein chains and the oxygenated and 
deoxygenated forms of these. Block C represents the binding of H
+
 to the side chains of the 
amino acids. 
In principle, 6 mass balance equations are required, one to describe each of the components of 
blood. Equation 1r accounts for the total CO2 in plasma and red blood cells. Equation 2r accounts 
for the total non-bicarbonate buffers. Equation 3r accounts for the total haemoglobin in blood 
(Hb) and can be written in two ways: by counting the different chemical forms of the amino end 
of the haemoglobin chains; or by counting the different chemical forms of the amino side chain 
buffers (RH, R
-
) (equation 3br).  Equation 4cr, accounts for the total buffer base in whole blood 
(BB), defined as the total concentration of weak base in blood which is written as a weighted 
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sum of that due to plasma buffers (equation 4ar) and that due to erythrocyte buffers (BBe) 
(equation 4br). Equation 5r accounts for the total oxygen. No mass balance equation is included 
in the model for 2,3 DPG, assuming its value remains constant. 
 
 
Figure 5 – A mathematical model of the acid-base chemistry in blood [63]. (With kind 
permission from Springer Science+Business Media: Eur J Appl Physiol, Mathematical modelling 
of the acid-base chemistry and oxygenation of blood – A mass balance, mass action approach 
including plasma and red blood cells, 108, 2010, page 485, S.E Rees, E.Klæstrup, J. Handy, S. 
Andreassen, S.R. Kristensen, Figure 1B) 
 
In addition 9 mass action equations (6r-14r) are required to account for the 9 reactions buffering 
H+ (R1r – R9r). Mass action equations could be formulated representing the remaining 5 
reaction equations (R10r-R14r) representing the oxygen binding to haemaglobin. Instead, a 
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published model of the oxygen dissociation curve (ODC) [41,64] is included (equation 15r), and 
equations are included which define SO2 from the other model variables, by counting either the 
amino ends (equation 16r) or the side chains (equation 17r). 
Other equations describe the physico-chemical properties of blood. Equations 18r-21r describe 
the solubility of O2 and CO2 in plasma and red blood cells. Equation 22r states that the plasma 
and erythrocyte fractions sum to 1. Equation 23 states that the haemoglobin concentration in 
erythrocyte is a constant value of 21 mmo/l, such that the fraction of erythrocyte can be 
calculated as the haemoglobin concentration in blood divided by 21. A modified form [39] of the 
empirical relationship relating pH in the plasma and red blood cells derived by Funder and Weith 
[65], is used to describe the link between plasma and red blood cells acid-base status without the 
need to represent electrolyte transport across cell membranes.  This simplification means that the 
model cannot calculate values of electrolytes in the plasma and red blood cells.  
Equation 25r, the calculation of base excess (BE) as the concentration of buffer base above 
normal (nBB). Equations 26ar and 26br, represent the two approaches to catering for electrical 
neutrality as either anion gap (Ap
-
), or strong ion difference (SID). 
The parameterization of this model is described in detail in Rees and Andreassen [62]. The 
parameter describing bicarbonate buffering (pKHCO3) in the plasma and erythrocyte was fixed 
at the well know value. The parameter describing non-bicarbonate buffering in plasma (pKap) 
was estimated from only two data points, with measured values of pHp and PCO2. The 
parameters describing heamoglobin buffering in fully oxygenated blood (pKzo, pKco) were 
estimated from only three data points with measured values of pHp and PCO2, and a value of the 
normal buffer base in erythrocyte (BBe). The  parameters describing haemoglobin buffering in 
fully deoxygenated blood (pKzd, pKcd) were estimated from only two data points, the Haldane 
coefficient at pHe = 7.2 in the absence of CO2  and the Haldane coefficient at pHe = 7.2, at PCO2 
= 5.33 kPa [60,61]. 
Applying this model in a ventilator management system required including the blood model as 
part of a whole body model including circulation, respiration and other body stores of the 
components of blood related to acid-base and oxygen status. This model, described in detail in 
Andreassen and Rees [66], is illustrated in figure 6. 
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Figure 6 – the mathematical model of whole-body O2 and CO2 transport. Reproduced from [66] 
with kind permission of Begell House inc. 
This model includes the model of blood, plus additional equations describing the acid-base 
chemistry of interstitial fluid and tissues. The model also includes differential and other 
equations describing transport of O2 and CO2 between compartments representing tissues, 
interstitial fluid, arterial and venous blood, and lungs as illustrated in figure 6. These equations 
have been described in detail previously [66]. Briefly, equations N17 and N18 are differential 
equations for updating the state variables of the lung compartment, i.e. the fraction of O2 and 
CO2 in the alveoli; equation N19 describes alveolar ventilation; equations N20-N21 and N27-
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N28 describe the transport of O2 and CO2 between the lungs(l), environment(e) and alveoli(A); 
equations N22 and N23 calculate alveolar gas pressures from end tidal fractions accounting for 
the partial pressure of saturated water vapour; equations N24 and N25 describe equilibration 
between alveolar air and capillary blood; equations N26 and N29 described the assumption of no 
strong acid production in the lungs, i.e. equivalence in BE between lung capillary, mixed lung 
capillary and mixed venous blood; equations N30 and N31 describe mixing of lung capillary and 
pulmonary shunted blood; equations N32-N34 are differential equations for updating state 
variables in the arterial compartment, i.e. total CO2 concentration, base excess, and total O2 
concentration; equations N42-N44 are similar differential equations for the venous blood 
compartment; equations N4 and N5 describe the assumption of equilibrium of bicarbonate and 
CO2 between venous blood and interstitial fluid; equation N35 expresses the assumption of 
steady state for O2 between tissue, interstitial fluid and tissue capillary blood with equivalence of 
flows between these, all of which may be calculated from the Fick equation; equation N36 
describes the transport of CO2 between interstitial fluid and capillary blood; equation N37 
describes the change in BE between arterial and venous blood; equations N38 and N39 are 
differential equations for updating state variables in the combined interstitial fluid and tissue 
compartment, i.e. total CO2 concentration and BE; equations N40 and N41 describe total CO2 
and BE in the combined interstitial fluid and tissue compartment as the weighted sum of the 
individual concentrations. 
3.3 Model validation.     
 The models of blood and whole body transport have been evaluated to see if they can simulate 
correctly data describing plasma, red blood cells, whole blood and whole body transport of O2 
and CO2. In addition the model of acid-base has been evaluated to see whether it has sufficient 
complexity to be useful in the INVENT system. These evaluations were performed in two 
phases: an evaluation of the models against previously published data; and evaluation of the 
models against studies specifically designed to test relevant functionality. These two evaluation 
phases are now discussed in turn. 
3.3.1Evaluation against previously measured data  
This evaluation was reported in Rees and Andreassen [62] and Andreassen and Rees [66]. In 
Rees and Andreassen [62] the model of blood was shown to accurately reproduce data obtained 
from Siggaard-Andersens curve nomogram [42, 43], as exemplified in figure 7A. These 
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simulations accurately described: the addition or removal of CO2 or strong acid to plasma; the 
addition or removal of CO2, strong acid, or haemoglobin to blood; and the effects of 
deoxygenating erythrocyte or blood at a wide range of values of pH and PCO2.  In addition the 
model was shown to be able to simulate data [60,61] describing values of the Haldane coefficient 
and Base Excess coefficient over a wide range of values of pH and PCO2, as exemplified in 
figure 7b. This evaluation illustrates the generality of the model in that substantial functionality 
can be validated in a model which includes relatively few parameters, identified from very little 
data.  
In Andreassen and Rees [66] the model of whole body CO2 and O2 transport was shown to 
reproduce the results of published experiments when used to simulate: normal conditions in the 
lungs, arterial and venous blood, interstitial fluid, and tissues during normal ventilation and the 
characteristic two-exponential response to changes in minute ventilation [67]. In addition, a 
steady state version of the model could reproduce the relationship between arterial blood values 
of PCO2 and HCO3 during inspiration of different fractions of CO2, as illustrated in figure 8. This 
latter data set is the characteristic distribution of HCO3 between blood and interstitial fluid [47], 
which was the basis for the criticism of BE leading to the Great-Transatlantic debate. 
 
Figure 7 – Validation of the model of acid-base chemistry – A) reproduction of buffer curves on 
the Siggaard-Andersen curve nomogram [43,44] (crosses: model simulations, soid lines: 
nomogram buffer lines), and B) reproduction of Haldane coefficients (Hc) [60] at varying pH 
(crosses: data from [60], curves: model simulations. Both figures are reproduced from [62] with 
kind permission of Begell House inc. Details of models simulations can be found in [62]. 
 A B 
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Figure 8 – Validation of the model of acid-base chemistry – reproduction of in whole body PCO2 
versus HCO3 curves plotted against the data of [47]. Reproduced from [66] with kind permission 
of Begell House inc. Details of models simulations can be found in [66]. 
 
3.3.2 Evaluation with studies designed specifically to test relevant functionality 
The purpose of the model of acid-base chemistry described in [62] was to both have the 
functionality of the models of Siggaard-Andersen, i.e. including red blood cells and Bohr-
Haldane effects; with the formulation of Stewart, i.e. the mass-action mass balance formulation. 
The formulation of Stewart was necessary to enable the easy use of the model in a whole body 
compartmental model, where simulations such as the mixing of blood are necessary. 
To evaluate whether the acid-base model could accurately and precisely describe blood mixing a 
series of studies was designed in which blood samples at different gas partial pressures are 
mixed, and the model evaluated to see if it can simulate this mixing process. Three studies were 
designed 
1) Mixing of blood with different PCO2 and PO2 levels, but where all other factors, i.e. 
plasma protein concentration, haemoglobin concentration, electrolyte concentrations 
and metabolite concentrations were normal. 
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2) A similar study to 1), but using the blood from acutely admitted patients presenting at 
departments of lung medicine, such that this blood may have abnormal levels of other 
variables. 
3)  A similar study to 1), but using the blood from patients residing at the intensive care 
unit, such that this blood may have severely abnormal levels of other variables. 
These three studies are underway with, at the time of writing this dissertation, only the first 
having reached publication [63]. A short summary of the methods and results of that study now 
follows. 
Peripheral venous blood was sampled from 21 normal subjects into a 9 ml venous blood 
collection tube. A 1-2 ml sample of blood was drawn from the 9 ml syringe into a syringe which 
was labeled ‘d’ for deoxygenated (i.e. venous blood), and analysed immediately to obtain 
standard acid-base electrolyte and metabolite values. A further 1 ml sample was drawn from the 
same 9 ml syringe into a syringe and labeled ‘m’ for mixed. The remaining approximately 6 ml 
was then poured into a beaker open to the air for 15 minutes. A 1-2 ml sample was then drawn 
from the beaker into a syringe labeled ‘o’ for oxygenated. A further 1 ml was then drawn into the 
syringe marked ‘m’. The blood samples marked ‘o’ and ‘m’ were then analysed to obtain values 
of acid-base, oxygenation, metabolite and electrolyte status. 
In order to estimate the fractions of “d” and “o” in the mixed sample 30 µl of physiological 
saline containing creatinine at a concentration of 120 mmol/L, was added to the beaker at the 
start of the period where blood was exposed to room air.  Creatinine was measured in all samples 
as part of acid-base, oxygenation, metabolite and electrolyte status.  
The model was used to simulate this mixing process as illustrated in figure 8, according to the 
steps described in the legend. 
25 
 
 
Figure 9 – Use of the mathematical model of acid-base [62] to simulate the mixing of blood. Step 
A represents determination of the values of variables (pH, PCO2, PO2, Hb, DPG and Atot) 
necessary for solution of the acid-base model [62, 63]. In Step B the acid base model [62,63] is 
used to calculate the concentration of blood components. Step C simulates mixing as a weighted 
sum of concentrations in the two samples; In Step D variables representing the mixed sample 
(BBc, tcCO2, tcO2, Hbc, DPGc, Atotc) are used to solve the acid-base models for all variables. 
(With kind permission from Springer Science+Business Media: Eur J Appl Physiol, 
Mathematical modelling of the acid-base chemistry and oxygenation of blood – A mass balance, 
mass action approach including plasma and red blood cells, 108, 2010, page 489, S.E Rees, 
E.Klæstrup, J. Handy, S. Andreassen, S.R. Kristensen, Figure 2) 
 
Figure 10 illustrates the Bland-Altman plots from Rees et al. [63] comparing values of pH, 
PCO2, PO2 and SO2 in measured (m) and calculated (c) values of mixed blood samples using the 
model of Rees and Andreassen [62]. For all variables, model calculated values are close to those 
measured with very little bias and a precision similar to that for direct measurement of blood in 
routine clinical practice. This shows the ability of the model to simulate the mixing of blood 
samples with the same electrolyte and metabolite status, but with different partial pressures of O2 
and CO2. Correct mixing of these samples therefore evaluates the ability of the model to account 
for the effects on acid-base status of respiratory disturbances which simultaneously change O2 
and CO2. Studies 2 and 3 are required to perform the same evaluation in situations of abnormal 
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plasma protein concentration where the fixed values of Atot used here (Atot = 23.5 meq/l) may 
not be appropriate and where electrolyte or metabolite values may be disturbed.  
 
Figure 10 – Bland-Altman plots comparing measured (m) and calculated values in mixed blood 
samples. Two blood samples were taken for each subject and are plotted as crosses and circles, 
respectively. Dashed lines represent the mean bias ± 2 SD for crosses, and solid lines for circles 
[63]. (With kind permission from Springer Science+Business Media: Eur J Appl Physiol, 
Mathematical modelling of the acid-base chemistry and oxygenation of blood – A mass balance, 
mass action approach including plasma and red blood cells, 108, 2010, page 491, S.E Rees, 
E.Klæstrup, J. Handy, S. Andreassen, S.R. Kristensen, Figure 3) 
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3.4 ARTY – System development and clinical application.     
As postulated in the introduction to this dissertation, development of physiological models tends 
to raise new interesting questions relating to our understanding of physiology and to potential 
clinical and commercial applications of the models. 
One such idea is presented in this section of the dissertation, the idea being that blood taken from 
peripheral venous measurements and analysed for acid-base and oxygenation status can be 
mathematically arterialized to calculate the equivalent variables in arterial blood. This idea, and 
the associated method, has been patented [68] and hopefully will be available commercially in 
the near future. 
The idea has several possibilities for improving patient care: Patients residing in Departments of 
lung medicine typically do not have indwelling catheters. Evaluation of acid-base and 
oxygenation status therefore typically involves painful arterial puncture with the associated risks 
of complications. Typically these patients are admitted for a period of 4-5 days, and during that 
time have repeated arterial samples. Replacement of these with mathematically arterialized 
venous samples therefore represents a real potential benefit to the patient. In addition, patients 
acutely admitted to the emergency medical department have arterial punctures made only if 
suffering from dyspnea. For these patients painful arterial punctures might be eliminated by the 
technique. If admitted to the emergency medical department without dyspnea no quantification 
of acid-base and oxygenation status is performed, this being despite the fact that peripheral 
venous blood samples are typically taken in all patients. Analysis of acid-base and oxygenation 
status using the technique may provide useful screening in these patients.  
The arterialisation technique is described in the next section, with focus on how the 
mathematical model of acid-base and oxygenation status is applied. The evaluation of the 
method has until now followed a two stage process 
1) Evaluation in a broad range of intensive care patients. 
2) Evaluate in patients residing in the department of pulmonary medicine. 
The first of these has been the focus of a PhD project [69, 70, 71]. Since the results of these 
stages are similar only the latter will be discussed in this dissertation. 
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3.4.1 Mathematical arterialisation method         
Figure 11 illustrates the method for calculating values of arterial acid–base status from values in 
the peripheral venous blood, plus arterial oxygen saturation measured with a pulse oximeter. The 
principle of the method is that venous values can be mathematically transformed into arterial 
values by simulating the transport of blood back through the tissue.  
 
Figure 11 – Mathematical arterialisation [72]. (Reprinted from: Comput Methods Programs 
Biomed., 81(1), Rees S.E, Toftegaard M, Andreassen S., A method for calculation of arterial 
acid-base and blood gas status from measurements in the peripheral venous blood, page 19, 
2006, with kind permission from Elsevier. 
The steps included in the method are presented in detail in Rees et al [72] with a brief summary 
given here. Step A: An anaerobic venous blood sample is drawn and measurements of pHv, 
PCO2,v, SO2,v, PO2,v, Hbv, Methaemoglobin (MetHbv), and carboxyhaemoglobin (COHbv) are 
taken. Step B: Venous measurements are entered into the acid base model to calculate the total 
CO2 concentration (tCO2,v), total O2 concentration (tO2,v), base excess (BEv), and the 
concentration of 2,3-diphosphoglycerate (DPGv) in venous blood. The units of all these variables 
are concentration, as for the blood mixing experiments described in the previous section, these 
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variables are therefore convenient to perform simulations of the addition or removal of gasses. 
Using the variables describing venous blood (tCO2,v, tO2,v, Hbv, BEv, DPGv, tNBBp,v) calculation 
of the respective variables in arterial blood can now be performed (Step C). Concentrations of 
haemoglobin, the plasma nonbicarbonate buffer, and 2,3-DPG are assumed to be the same in 
arterial and venous blood. The amount of strong base added to the blood during is passage 
through the tissue is assumed to be zero, i.e. BEav= 0 mmol/l and therefore BEa = BEv. 
Calculation of the total concentration of O2 and CO2 in arterial blood is performed by simulating 
addition of a concentration of O2 (ΔO2), to the venous blood and removing a concentration of 
CO2 (ΔCO2, where ΔCO2 =RQ *ΔO2) from the venous blood. The acid-base model is then used 
to calculated the remaining variables describing arterialised blood, i.e. pHa, PCO2,a, PO2,a, and 
SO2,a (Step D). Calculated arterialised oxygen saturation SO2,a is then compared with that 
measured by the pulse oximeter (SpO2)  (Step E), the difference between the two giving an error 
= SO2,a −SpO2. By varying the value of ΔO2 and repeating steps C–E (Fig. 1), a value of ΔO2 can 
be found for which the error is zero. At this point, the ΔO2 represents the concentration of O2 
added, and RQ multiplied by ΔO2 the concentration of CO2 removed, so as to transform venous 
to arterialised blood. For this value of ΔO2, calculated values of all variables describing 
arterialised blood (pHa, PCO2,a, PO2,a, and SO2,a) should be equal to measured arterial values. 
 
3.4.2 Evaluation of the ARTY method in patients residing in the department of pulmonary 
medicine. 
This section describes a summary of the study published in [73]. Arterial and peripheral venous 
blood was sampled from 40 patients previously diagnosed with chronic lung disease, and either 
acutely admitted or visiting the Department of Respiratory Diseases for their biannual clinical 
assessment. Patients’ acid base status was described by median (range) values as follows: pH 
7.418 (7.237–7.508), PCO2 6.26 (3.92–11.2) kPa, PO2 8.97 (6.11–15.70) kPa. Peripheral venous 
and arterial blood samples were taken along with pulse oximetry measurement of SpO2. The 
ARTY method was then used to calculate arterial values from peripheral venous values and 
calculated arterial values (ca) compared with measured (a) using Bland-Atlman plots, and scatter 
plots of measured versus calculated. Values of bias and standard deviation between measured 
and calculated arterial values were calculated along with values of correlation coefficients (r
2
) 
and parameters for regression lines. The results of this comparison can be seen in figure 12. 
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Figure 12 – Evaluation of the arterialisation method in patients residing in pulmonary medicine. 
a, c and e) Bland–Altman and b, d and f) scatter plots comparing measured arterial (a) and 
calculated arterial (ca) values. Reproduced from [73], with kind permission of the European 
Respiratory Society Journals Ltd. 
Measured and calculated values of pH and PCO2 correlated well, with the difference between 
them having a very small bias and standard deviation (pH -0.001±0.013, PCO2 -0.09±0.28 kPa).   
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The method was also shown to calculate PO2 sufficiently accurately for clinical use (PO2 
0.11±0.53 kPa), in situations where SpO2 ≤ 96%, i.e. in all but 4 of the patients. Calculated 
correlation coefficients were (r
2
 for pH= 0.95, r
2
 for PCO2 = 0.98, r
2
 for PO2 = 0.86).  
 
3.4.3 Sensitivity of the ARTY method to assumptions and measurement error. 
The results of this study were very similar to those published describing, primarily, patients 
residing in the ICU [71]. However, to understand whether these results reflect in a broader 
population, it was necessary to consider the sensitivity of calculations to measurement error and 
to the assumptions contained in the method. This sensitivity analysis was published in [72,73], 
and a summary follows. 
Two major assumptions exist in the method: first that the amount of strong acid added to the 
blood as it passes the tissues is a very small or zero, i.e. that (ΔBEav) is approximately zero; and 
that the respiratory quotient over the sampling site may be assumed constant and approximated 
as an average value (RQ= 0.8). These assumptions are justified by the usual clinical practice of 
taking peripheral blood samples in only warm well perfused sites, where anaerobic metabolism is 
probably not substantial, and transient acid-base disturbances are unlikely. 
Sensitivity analysis [72] has shown that variation in ΔBEav of 0.2 mmol/L gives rise to quite 
small errors in calculated pH, PCO2 and PO2 of 0.006, 0.08 kPa and 0.07 kPa, respectively. In 
addition, the results presented in our studies [71,72] are inconsistent with large changes in base 
excess across the peripheral sampling site. Sensitivity analysis has also shown [72] that the 
literature reported variation in RQ variation of 0.08 gives rise to only small errors in pH, PCO2 
and PO2 of 0.005, 0.10 kPa and 0.06 kPa, respectively.  
Measurement errors can be present in the measurement of venous blood and in pulse oximetry 
SpO2. Rees et al [72] showed that calculations performed using the method are insensitive to 
errors in measurement of venous blood gases. The standard deviation of measurement in SpO2 
reported by large European studies is quite large, i.e. 2%. To be useful, it is therefore important 
that the method is tolerant to pulse oximetry errors as much as ± 4%, i.e. the 95% confidence 
interval. Errors in SpO2 of ± 4% have been shown to give only small variation in calculated 
arterial pH and PCO2, these errors being fairly constant over the range of SpO2 values [73].  
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The errors in calculation of arterial PO2 due to pulse oximetry are illustrated in figure 13, for the 
clinically interesting range of PO2. As discussed previously [73], a pulse oximeter that reads too 
low, as represented by the bottom dashed line on the figure, potentially results in unecessary 
supplementary oxygen, fluids or other intervention, i.e. there is no risk of hypoxaemia due to the 
pulse oximeter reading too low. For a pulse oximeter that overestimates oxygen saturation, 
maximal errors exist when the true value is ≥ 96%.  These errors are clinically unimportant, as at 
these levels the patient does not require oxygen therapy. The effects of error in SpO2 on the 
assessment of low arterial PO2 is seen figure 13. Conveniently, errors in predicted PO2 reduce at 
lower oxygen levels, i.e. the error is least important where the information is most useful. To 
illustrate this, three points were drawn on this figure and the following conclusions drawn: if the 
calculated PO2 is ≥12.5 kPa, then the true PO2 is >9 kPa (point A); if the calculated PO2 is ≥10 
kPa, then the true PO2 is >8 kPa (point B); if the calculated PO2 is ≥8 kPa, then the true PO2 is 
>7 kPa (point C).  
 
Figure 13 – ARTY simulations illustrating the sensitivity of calculated arteral PaO2 (Pca,O2)to 
variation in peripheral oxygen saturation (Sp,O2) Plots are drawn for mean Sp,O2 (solid curve) 
and mean Sp,O2 ± 4% (dashed line). Reproduced from [73] with kind permission of the 
European Respiratory Society Journals Ltd. 
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3.5 Summary of chapter. 
 
This chapter has discussed the contrasting approaches to modeling of acid-base chemistry 
present in the literature. In doing so it has highlighted the need for models of a mass-action mass-
balance nature, which have sufficient complexity to simulate change in any of the components of 
blood related to the respiratory gas and acid-base status. A mathematical model has been 
developed of the acid-base chemistry of blood using this mass-balance mass action approach and 
including the necessary functionality. This model has been included in a whole body model of O2 
and CO2 transport, and these models have been validated against literature data, and from 
experiments involving the mixing of blood samples at different gas levels. The mathematical 
model of the acid-base chemistry of blood has been included in a system for converting the acid-
base and oxygen status of peripheral venous gas to values in arterial blood. This technique has 
been described, as has its sensitivity to measurement error and assumptions, and its validation in 
patients with chronic lung disease.  
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4. Decision support for mechanical ventilation 
 
4.1 Introduction 
As reviewed recently [74,75], there currently exist numerous systems designed to either 
automatically control or provide decision support for the process of selecting mechanical 
ventilator settings. The most successful of these, evaluated in randomized controlled trials 
[1,2,3,4], and commercialized [1,4], are based on automating the heuristic reasoning of the 
clinician, through sets of rules. Those commercialized (SmartCare, ASV), focus on patients 
ventilated in support modes. SmartCare [76] is used to keep the patients with a ‘‘zone of 
comfort’’ for levels of CO2 and the patients work of breathing (SmartCare); whilst adaptive 
support ventilation (ASV) [77] aims to optimize the balance between respiratory rate, tidal 
volume and inspiratory pressure from a specified required minute volume. For SmartCare, a 
strategy of regularly reducing pressure support, whilst keeping the patient within normal CO2 
levels and preventing exhaustion has been shown to reduce the time spent on mechanical 
ventilation, and reduce the number of unnecessary re-intubations following extubation [1]. Use 
of ASV has been shown to maintain PaCO2 levels at clinical values with reduced peak airway 
pressure [78]. Development of intelligent systems for mechanical ventilation has therefore 
proved profitable. However, in general these systems have been applied to patients in support 
ventilator modes where the main clinical issues are the time to wean patient balanced against 
CO2 levels and the potential to exhaust the patient. In these patients serious abnormalities in gas 
exchange or lung mechanics are not the primary consideration for selecting ventilator settings. In 
patients with ALI or ARDS, selection of appropriate mechanical ventilation has been associated 
with reduction in mortality [80]. In these patients a deeper understanding of the patient’s 
abnormalities may be necessary to provide corret therapy. Currently no commercial DSS are 
available which target this patient group, and it can be argued that systems providing a deeper 
understanding, such as model-based systems, are required. 
Few DSS for mechanical ventilation, based upon physiological models, have been developed 
[80, 81, 82], with currently these systems having been evaluated by only simulation studies [80], 
via retrospective evaluation [81], or in small prospective studies [80,83]. Apart from the system 
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described in this dissertation, of the systems based upon physiological models, only the Sheffield 
Intelligent Ventilator Advisor (SIVA) system [82] remains under development. 
This section describes the structure and function of the intelligent ventilator (INVENT) system, 
plus the current status in its evaluation and integration in intensive care. This system includes 
physiological models which are simple enough to be parameterized from clinical data, providing 
a deeper understanding of the patient state, and enabling predictions of “what if” scenarios; and 
utility functions to enable quantifiation of the ‘goodness’ of simulated outcomes, enabling 
selection of ventilator settings which maximize expected utility in a decision theoretic approach. 
This system is designed for controlled ventilator modes, focusing on the situations where a 
deeper understanding of the patient may be most profitable. 
 
4.2 The Intelligent Ventilator (INVENT) system. 
Figure 1 illustrates the structure of INVENT described previously [84]. The model of pulmonary 
gas exchange included in ALPE is integrated with the acid-base model, the whole body O2 and 
CO2 transport model and a rudimentary model of lung mechanics. These models are tuned to the 
individual via parameter estimation, this being possible by measures of ventilatory pressures and 
volumes, and by performing an ALPE experiment. The models can then be used to simulate the 
effects of changes in ventilator settings on both pressures and volumes in the lung, and the 
oxygenation and acid–base status of the blood. A steady state version of the whole body model 
of O2 and CO2 transport is included in the system allowing instantaneous predictions of steady 
state conditions. Also represented in the system are mathematical penalty functions which 
quantify clinical preference to the goals and side effects of ventilator therapy including: 
sufficient oxygenation; minimizing the risk of acidosis and alkalosis, and minimizing the risk of 
ventilator induced lung injury. An optimization algorithm is included to automate the process of 
finding the ventilator strategy which minimizes the total penalty, this then being regarded as the 
best setting.  
The models of gas exchange, acid-base and oxygen status and whole body gas transport have 
already been described as part of this dissertation. For completeness, this section describes the 
model of lung mechanics used in the system and the penalty functions. 
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Figure 14 - The structure of the decision support system, illustrating the components of the 
system (ovals), and the functionality (dashed lines) [84]. (With kind permission from Springer 
Science+Business Media: J Clin Monit Comput, Using physiological models and decision theory 
for selecting appropriate ventilator settings, 20, 2006, page 423, Rees S.E, Allerød C, Murley D, 
Zhao Y, Smith B.W, Kjærgaard S, Thorgaard P, Andreassen S, figure 1) 
The INVENT system is currently developed for controlled ventilator modes, i.e. where the 
patient does not have any spontaneous ventilation. This means that the system is intended for 
application in the most severely ill of intensive care patients. The current model of lung 
mechanics included in the system is very simple, and analogous to those used in mechanical 
ventilators. This model describes the relationship between peak inspiratory pressure (PIP) and 
tidal volume as a one compartmental model with a value of dynamic compliance (ml/cm H2O)  
representing the whole lung, calculated as the change in volume, i.e., VT, divided by the 
corresponding change in pressure, i.e. PIP minus positive end expiratory pressure (PEEP). The 
assumption of constant dynamic compliance during controlled ventilation is only true for 
constant inspiratory flow, pressure and volume. Techniques exist for separating the effects of 
flow, volume and pressure changes on lung mechanics and these broadly fall into two types; 
those which identify characteristics from the routine ventilator cycle of the patient, e.g.  
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Spirodynamics [85,86], and those which perform long inflations and deflations techniques, often 
at low flows, to separate resistance and compliance and understand the changes in these variables 
at different flows, pressures and volumes [87,88,89].  The INVENT team has been involved in 
developing a technique which falls into the latter group [90]. This can identify the mechanical 
properties of the respiratory system rapidly in a pulsed inflation-deflation procedure. However, 
like all long inflation-deflation techniques, it suffers from the limitations of perturbing the patient 
outside their normal ventilator strategy, increasing ventilator pressures and the risk of the need 
for extra muscle relaxation to prevent the patient fighting the maneuver. Although involved in 
the development of such techniques, the INVENT team has not then incorporated them into the 
INVENT system.  
The use of constant dynamic compliance places constraints on the simulations performed using 
the system. One possible solution is to vary inspiratory volumes or pressures over small enough 
ranges so that the pressure volume curve of the lungs can be considered linear and the 
compliance constant. In practice the ‘optimal’ settings obtained from the system might be seen as 
targets and small steps in ventilation taken toward these targets with checks for constant 
parameter values along the way. 
The system includes mathematical functions of clinical preference, expressed as penalties 
associated with certain of the models variables, in a decision theoretic approach [5]. Penalty 
functions, illustrated in figure 15, are associated with: SaO2 and SvO2, to represent local and 
global hypoxaemia; arterial pH, to represent acidosis and alkalosis; inspiratory oxygen level, to 
represent the risk of oxygen toxicity and absorption atelectasis; and positive inspiratory pressure, 
to represent the risk of barotrauma. The penalty associated with the risk of barotrauma is scaled 
with respiratory frequency (f), such that higher frequencies at the same pressure incur a greater 
penalty. The shape of the functions has been derived from input provided by a domain expert and 
the functions scaled, such that the total penalty can be represented as a sum of the individual 
functions. Scaling was performed by modifying the functions such that the system behaved 
similarly to an expert over 20 test case patients. It is important to note that these functions are 
extremely subjective and that different functions may be defined for different clinicians or 
intensive care specialties. This can be seen as strength of the approach, as explicit formulation of 
such functions may promote discussion of rational strategy toward ventilator management. 
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Figure 15.  The penalty functions included in the DSS. Reproduced from [84] with permission. . 
(With kind permission from Springer Science+Business Media: J Clin Monit Comput, Using 
physiological models and decision theory for selecting appropriate ventilator settings, 20, 2006, 
page 425, Rees S.E, Allerød C, Murley D, Zhao Y, Smith B.W, Kjærgaard S, Thorgaard P, 
Andreassen S, figure 3) 
 
4.3 Using the INVENT system.  
Figure 16 illustrates the user interface for INVENT III including a patient. INVENT III is that 
version of INVENT which provides advice on three settings:  inspired oxygen fraction, tidal 
volume and respiratory frequency.  As described in [84], the interface is divided up into three 
sections, the left hand side (LHS), right hand side (RHS) and bottom of the screen. In the LHS 
and RHS variables have three different values in 3 columns, which represent respectively the 
measured (Current), inputs or outputs from model simulations (Simulated), and the results of 
optimisation (Optimal). The LHS contains the ventilator settings, penalties and function buttons 
of the system. The RHS contains data describing the lung, arterial blood and venous blood. The 
bottom of the screen includes the patient specific parameters. These are organized according to 
organ system and include parameters describing lung gas exchange and mechanics (shunt, fA2, 
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Vd, compliance); blood (2,3 diphosphoglycerate (DPG), haemoglobin (Hb), 
carboxyhaemoglobin(COHb), methaemoglobin (MetHb), temperature(Temp));  circulatory status 
(cardiac output(Q); and metabolic status (oxygen consumption (VO2), carbon dioxide production 
(VCO2)).  
The system is used in three steps. First, the physiological models are fitted to the patient data, so 
as to estimate patient specific values of the physiological models’ parameters. Second quality of 
the model fit to the data can be evaluated. Third the clinician can perform simulations to test 
various ventilator strategies, and ask INVENT for the optimal ventilator settings. The details of 
these steps are described in [84]. For the patient illustrated in Figure 16 the DSS suggests 
optimal ventilator settings reducing FIO2 from 38.0% to 30.6%, with an almost negligible 
increase in tidal volume. These settings gives an ‘optimal’ SaO2 of 96.7%, and hence reduction 
in the total penalty from 0.054 to 0.040, primarily due to a lower oxygen toxicity penalty, which 
outweighed the increased penalty on hypoxia.  
To enable integration of INVENT into the intensive care a system has been developed (ICARE) 
[91], which includes software for communication with standard ICU devices and a database. 
ICARE also includes functionality for ranking the stored data, depending on its source, and to 
automatically perform physiological calculations as new data present.   
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Figure 16 – The user interface for INVENT III. Reproduced from [84] with permission. ("With 
kind permission from Springer Science+Business Media: J Clin Monit Comput, Using 
physiological models and decision theory for selecting appropriate ventilator settings, 20, 2006, 
page 426, Rees S.E, Allerød C, Murley D, Zhao Y, Smith B.W, Kjærgaard S, Thorgaard P, 
Andreassen S, figure 4) 
 
4.4 Evaluation of the INVENT system.  
To evaluate the INVENT system requires validation of the physiological models and preference 
functions included in INVENT, and evaluation of the advice provided by the INVENT system.  
The validation of the physiological models included in INVENT has been described in the 
previous chapters of this dissertation, apart from the validation of the representation of lung 
mechanics. The limitations of the simple model of lung mechanics used here are well known, 
and it remains to be seen whether we have selected a useful clinical approximation to reality. 
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A systematic study is currently underway, as part of a PhD project, to evaluate the utility 
functions included in INVENT [94]. In this study a set of 10 patient cases are presented, via 
INVENT’s physiological models, to 10 expert clinicians. The clinicians select the ventilator 
setting which, via simulation, give the patient state they regard as optimal. From the 10 clinicians 
and INVENT a set of 110 optimal suggestions are then generated. These are then returned to the 
clinicians for ranking. In doing so a quantitative picture can be obtained as to current clinical 
preference and the ability of the INVENT utility functions to capture this. In addition, this 
process gives an interesting insight into the consensus, or lack of it, in current clinical opinion 
toward ventilator management. 
Evaluation of the advice provided by the INVENT system has been structured in a series of 
investigations, illustrated in figure 17. 
Three different versions of INVENT are currently under development and evaluation: INVENT I 
optimizes only for FIO2. It includes physiological models of ALPE plus the utility functions for 
oxygenation and oxygen toxicity illustrated in figure 15. INVENT III optimizes for inspiratory 
oxygen, respiratory frequency and tidal volume. INVENT V, is planned to optimize over the 
settings of INVENT III plus PEEP and I:E ratio. 
 
 
Figure 17 – Development and evaluation of the INVENT system.  
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For each of the three systems a process of development, retrospective evaluation and prospective 
evaluation is being undertaken. The current status of each of the systems progress being shown 
in figure 17. INVENT I has been the subject of a PhD study [93], the system having been 
developed, retrospectively [94], and prospectively [95] evaluated.  Retrospective and prospective 
evaluation has given similar results, with the results of prospective evaluation being illustrated in 
figure 18 
 
 
Figure 18 – Prospective evaluation of INVENT I. Reproduced from [95], with kind permission 
from Elsevier. 
 
Figure 18 illustrates the levels of FiO2 and resulting SaO2 at baseline (A), selected by the 
clinician (B) and selected by INVENT I (C). INVENT achieved narrower ranges of FIO2 and 
SaO2 values than baseline or attending clinicians, suggesting standardized more effective use of 
FiO2.  In addition this study showed that INVENT was more responsive over time to changes in 
the individual patient state than clinical practice. 
INVENT III has been retrospectively evaluated as part of a current PhD project. Retrospective 
evaluation has taken place in a group of patients mechanically ventilated following coronary 
arterial bypass surgery [96]. In these patients the INVENT models were shown to fit well to the 
patient data, giving parameter values consistent with this homogenous patient group. The system 
suggested values of ventilator settings which can be considered clinically reasonable: suggesting 
lowering of FiO2 in situations of high SpO2 and increasing FiO2 in situations of low SpO2, whilst 
maintaining simulated SpO2 in the range 94.6 – 97.4 %; and suggesting lowering ventilation in 
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situations of high pHa and increasing ventilation in situations of low pHa these being achieved 
whilst maintaining simulated pH in the range 7.368-7.404, simulated values of PIP ≤ 
22.9cmH2O, and f ≤ 18 breaths min
−1
. 
 
4.5 Summary of chapter. 
This chapter has described the type and focus of current decision support systems for aiding in 
mechanical ventilation, highlighting the need for systems which are based on a deeper 
description of the individual patient state, possible with the use of physiological models.  The 
structure and function of the INtelligent VENTilator (INVENT) system has been described 
including its application of physiological models and utility/penalty functions in optimization of 
ventilator settings. An example of the use of INVENT has been presented, and the current status 
of development and evaluation summarized.  
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5 Discussion and Conclusions 
 
This dissertation is presented for the degree of Doctor of Technology. It is not intended to 
describe novel understanding of physiological or biochemical mechanisms, with much of the 
knowledge on these aspects included in this dissertation having been known for many decades. 
Similarly, it is not purely clinical, concentrating on the optimization of current therapy rather 
than the development of new. The focus of this work is therefore in the use of mathematical 
models to transfer physiological knowledge into clinical practice. This process is in many 
respects no more that scientific tidying-up, repackaging and formulating others understanding in 
a form which can be effectively included into useful clinical systems. However this process is 
both important and non-trivial. As commented by Burton on the subject of review articles 
“Cheaply extracting new meaning from costly, hard-won data is surely to be encouraged” [97], 
and mathematical models provide a mechanism of ensuring that this extraction is performed 
systematically and in a way which can be clinically applied. This is a non-trivial task as systems 
reaching commercialization and use, based on physiological models, require expertise in many 
scientific disciplines, e.g. physiology, biochemistry, biomedical engineering, medical informatics 
and clinical practice, as well as requiring researchers to be at least familiar with the practices of 
patent applications and starting up spin-off companies. Such research requires both broad teams 
of specialists, but also that each specialist is familiar and to some degree competent in many of 
these fields. The positive result is a challenging and multi-disciplinary environment, the negative 
is the risk of the researcher becoming a jack of all trades.    
Given then that the physiological and many of the clinical aspects of this dissertation are not 
novel, it is important then to highlight the novelty and contribution of this work. The following 
section reviews each of the chapters highlighting the contribution of this work, its relation to the 
literature and the potential for future research.  
 
5.1 Pulmonary gas exchange 
The basis of our understanding of pulmonary gas exchange was developed in the 1950s-1970s. 
During that period Riley and co-workers illustrated that information about some of the 
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components of gas exchange could be determined with systematic measurement of oxygen and 
CO2 in respiratory gasses and blood [98,99,100]. The limitations of the use of O2 and CO2 as 
tracers gasses to help understand gas exchange became increasingly well known and resulted in a 
leap in our understanding of pulmonary gas exchange with the development of MIGET [7]. 
Whilst physiological understanding of the pulmonary gas exchange in different lung disease is 
now well known, the systematic clinical application of this knowledge can be seen as poor, with 
the PaO2/FIO2 measurement, a measurement worse than those proposed by Riley and co-
workers, being the reference technique in the ICU. 
One of the contributions of this dissertation, and of the  INVENT team, has therefore been to 
look again at the use of O2 and CO2 as tracer gasses, aiming at incorporating physiological 
knowledge into clinical practice by finding a compromise between the complexity of MIGET 
and the over simplification of the current clinical practice. In addition the aim has been to use 
technology not available to Riley and co-workers, to extend the application of O2 and CO2 
measurements, not as a tool for understanding physiology but as tools to aid in clinical practice.   
In doing so we believe we have identified the most parsimonious model, describing pulmonary 
shunt, low V/Q and high V/Q from measurements routinely available in the clinic, along with a 
readily automatable variation in FIO2. This ALPE system has been developed, evaluated 
clinically in a range of patients, evaluated experimentally against MIGET, patented and 
commercialized.  
Whilst the clinical use of O2 in describing pulmonary gas exchange has been largely limited to 
the PaO2/FIO2 ratio, other technologies for describing pulmonary gas exchange at the bedside are 
beginning to enter clinical practice. Electrical impedance tomography is showing promising 
results in non-invasively characterizing tidal changes in ventilation and perfusion for individual 
regions of the lungs [101,102,103]. Vibration response imaging has also been shown to be able 
to non-invasively characterize regional ventilation in a range of patients on or off mechanical 
ventilation [104, 105]. 
Development of these new techniques raises the question as to whether the use of O2 and CO2 to 
describe pulmonary gas exchange has been superseded.  The answer is probably not.  Faster 
mainstream oxygen gas analysers are entering the market [106] meaning that an increasing 
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number of ventilator manufacturers are likely to combine O2 and CO2 measurements for 
metabolic monitoring, as is currently present in GE ventilators. In addition measurement of 
functional residual capacity can be made from variation in FIO2 and measurement of respiratory 
gasses [107], and this technology has reached product in GE ventilators (FRC INview) and 
research publications by Dräger Medical [108]. ALPE estimates could be obtained as a bi-
product of FiO2 variation to obtain FRC, meaning that there is potential for a combined 
understanding of lung volume and gas exchange from a simple clinical maneuver.  
The aspects related to pulmonary gas exchange included in this dissertation have focused on the 
use of oxygen as a tracer. The difference between oxygen in end expired and arterial gas is 
greatest when pulmonary shunt or low V/Q is present, meaning that as a tracer O2 gives most 
information about these compartments. In contrast CO2 is known to give most information about 
high V/Q regions. Karbing et al. [109], have shown that by using end tidal and arterial CO2 
measurements integrated into ALPE, the fractional perfusion distribution parameter (f2) of figure 
2 (chapter 2)  can also be estimated and high V/Q effectively characterized, as well as low V/Q 
and shunt. This finding raises new interesting clinical possibilities for ALPE. In patients with 
ALI or ARDS shunt and low V/Q are the primary problems of gas exchange. In contrast for 
patients presenting in departments of lung medicine with chronic obstructive pulmonary disease 
(COPD), high V/Q is often the predominant problem. The gas exchange of such patients is 
usually measured using carbon monoxide breathing techniques to calculate DLCO, the transfer 
factor. Once again, clinical practice therefore uses a single parameter to describe a ventilation 
perfusion distribution. This lack of complexity is clinically relevant amongst a heterogenous 
population of COPD patients. MIGET has taught us that patients with chronic bronchitis present 
with both high and low V/Q abnormalities, where as patients with emphysema typically have 
pure high V/Q [9]. The complexity of ALPE may therefore help in stratifying the heterogeneity 
of COPD, and ethical approval has been obtained to investigate this. 
In the ICU the incorporation of CO2 into ALPE and the identification of high V/Q may help in 
the monitoring of the effects of elevated ventilatory pressures, e.g. increasing PEEP or 
performing recruitment. An increase in pressure should shift the whole V/Q distribution to the 
right, with some of the shunt becoming low V/Q, low V/Q normalizing and normal V/Q 
becoming high V/Q.  It is interesting therefore to see if ALPE can accurately describe the effects 
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of pressure changes, and as such explain the patient specific response to changes in PEEP or 
recruitment. Ethical approval has been obtained to investigate this.  
 
5.2 Acid-base chemistry 
The biochemical and mathematical basis of the acid-base chemistry of blood has been well 
described for several decades. Both experimentally and in terms of mathematical formulation, 
Siggaard-Andersen and colleagues have accounted for a very large proportion of our current 
understanding.  
In his formulation Siggaard-Andersen used equations which are algebraically solvable, e.g. the 
van Slyke equation, and coefficients such as the buffer capacity to describe piecewise linearity. 
This formulation has the advantage of mathematical simplicity, but the disadvantage that the 
transparency of the link between the reaction equations and the mathematical equations is lost. 
This can lead to misunderstanding of the meaning of the mathematical equations. In part, 
Stewart’s formulation has remained close to the initial reaction equations. Whilst his equations 
do not therefore have the coverage of Siggaard-Andersen’s in describing blood, it can be argued 
that they are more transparent and therefore accessible to the non-mathematically inclined.  This 
type of formulation also has the benefit that appropriate, additive, state variables can be selected, 
a requirement which has been important for the development of INVENT 
From an acid-base perspective the major contribution of this work has been to illustrate the 
similarity between the approaches of Siggaard-Andersen and Stewart [52] and to develop a 
model with the coverage of Sigaard-Andersen and the structure of Stewart [62, 63]. This model 
has been validated against literature data illustrating that it could simulate the addition and 
removal of CO2 strong acid/base, and haemoglobin; and the effects of oxygenation or 
deoxygenation, including reproduction of values of the Haldane and BE coefficients. The model 
has also been validated in new data and shown to simulate accurately and precisely the mixing of 
blood samples at different PCO2 and PO2 levels [63], necessary for the INVENT system. New 
studies are underway to perform similar mixing in the blood from patients with disturbed 
electrolyte and acid-base status. 
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Like all models it includes approximations and assumptions which may not be correct. A 
detailed description of these assumptions is included in [62], and not discussed further here. 
Probably the major limitation of the model, in its current form, is the only remaining empirical 
equation (equation 24r, figure 5, chapter 3), which describes the relation between the pH in the 
plasma and red blood cells. This equation is used to eliminate the need to represent the transport 
of electrolytes and water over the red blood cell membrane when describing acid-base chemistry. 
For the purposes described in this dissertation this is not a limitation, however the intra- and 
extra-cellular fluid acid-base and electrolyte interaction is an interesting field where extension of 
the existing model could be helpful.       
The acid-base model was also included in a whole body model of O2 and CO2 transport [62] and 
shown to reproduce normal conditions in all compartments, the typical dynamic response to 
changes in ventilation, and the measured distribution of bicarbonate between blood and 
interstitial fluid Schwartz [47] 
The acid-base model has also been used in the ARTY system [72]. ARTY has been shown to 
calculate arterial values both accurately and precisely in patients residing in the ICU and 
departments of lung medicine. These data indicate a role for ARTY converted values of 
peripheral venous blood in clinical practice. In considering the role of ARTY it is important 
however, to ask the question as to whether ARTY is necessary or whether peripheral venous or 
indeed capillary blood could not be used to assess the patient’s acid-base status without the use 
of ARTY [110,111]. For pH and PCO2 it has been shown that the use of ARTY halves the 
standard deviation of the precision in which arterial values can be estimated [70, 71], and for 
calculation of PO2 no reasonable values can be obtained without ARTY [70]. These 
improvements are obtained cheaply, with the only overhead being the measurement of pulse 
oximetry SpO2. For pH and PCO2 it is possible that venous blood would nevertheless, be a 
reasonable method of classifying patients. Whilst some authors are addressing this issue [111, 
112] and clinical opinion is changing, there has previously been little clinical culture for 
interpretation of peripheral venous values of acid-base. Indeed, as recently as 2006, Radiometer 
Medical’s stated that “Venous samples are not recommended for whole-blood analysis, because 
venous PO2 and SO2 do not provide good diagnostic information on oxygen transport and 
oxygen uptake” [114]. Translating peripheral venous into arterial values can therefore been seen 
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as both a way to maximize the precision of its use, and as a valuable tool to promote the uptake 
of the use peripheral venous blood, enabling clinicians to view the results of venous 
measurement as more familiar arterial values. 
It has been argued that ARTY conversions of peripheral venous blood are no better than direct 
measurement of capillary samples [110]. However as commented in [111], these capillary 
samples are taken from sites either warmed or after application of vasodilatation cream, i.e. 
where the site has been mechanically arterialized. ARTY’s mathematical arterialisation does not 
require warming or the application of vasodilators making it a much simpler tool for clinical 
practice. 
The major assumption included in the ARTY method is that peripheral blood is sampled from 
well-perfused, warm tissue such that metabolism in that tissue is primarily aerobic. This means 
that the RQ over the sampling site would be between 0.7 and 1.0 and that the change in BE 
between arterial and venous blood would approximate zero. The quality of perfusion of a limb 
can be simply assessed in the clinic, and little difference in arterial-venous BE was seen in 
studied patients, even when no control was made to ensure normal perfusion [73].  
ARTY has currently been shown to calculate arterial values in patients from intensive care and 
departments of lung medicine at a single time point. Typically patients with COPD are admitted 
departments of lung medicine for a period of 4-5 days during exacerbation. It is important 
therefore that the method be evaluated over the duration of this period to see if peripheral venous 
blood can replace arterial in this context. Ethical approval has been obtained to investigate this.  
In addition, patients acutely admitted to the emergency medical department have arterial 
punctures made only if suffering from dyspnea. For these patients painful arterial punctures 
might be eliminated by the technique. If admitted to the emergency medical department without 
dyspnea no quantification of acid-base and oxygenation status is performed, this being despite 
the fact that peripheral venous blood samples are typically taken in all patients. Analysis of acid-
base and oxygenation status using the technique may provide useful screening in these patients. 
Ethical approval has been obtained to investigate these potential applications. 
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In the intensive care unit it is unlikely that ARTY calculated arterial values will replace direct 
arterial sampling in the majority of patients. Patients typically have indwelling arterial catheters 
for continuous measurement of blood pressure and for taking arterial blood for blood gas and 
acid-base. However, in patients without critical circulatory problems, or perhaps those presenting 
in high dependency environments, blood pressure could be monitored non-invasively with a cuff 
placed on the forearm or finger [115]. In this case, venous blood could be sampled from a central 
venous catheter, typically used for administration of fluid or medication. Use of ARTY to 
calculate arterial values from central venous blood may then eliminate the need for an arterial 
catheter in these patients.  
 
5.3 The INVENT system 
The contributions of this work, related to mechanical ventilation, have been in the design 
development and evaluation of a system for selecting appropriate ventilator settings. In doing so, 
the mathematical models of the previous chapters have been integrated with models of 
utility/penalty, hence separating physiological knowledge from clinical preference. The models 
can be tuned to the individual patient via parameter estimation, providing patient specific advice. 
The INVENT system has been integrated into a research based data collection system enabling 
prospective clinical evaluation. The INVENT team has shown prospectively that the system 
provides advice on FIO2 which is as good as clinical practice, and retrospectively that the 
physiological models fit well to clinical data and that the system provides reasonable suggestions 
of tidal volume, respiratory frequency and FIO2.  
Only one previous system has incorporated this level of physiology into a ventilator decision 
support system [81] and this system is no longer under development. This does not however, 
mean that the field has not moved forward in the past decade. Indeed, interest for intelligent 
ventilator type systems is growing, with many manufacturers having some variant. These range 
from new modes with increased intelligence or rule based systems, e.g. BIPAP, ASV or 
SmartCare, or even black box models of ventilator support based upon neurological drive 
measured from diaphragm electrical activity (NAVA). Interest in such systems is such that 
Hamilton Medical, one of the major manufacturers, markets its ASV mode under the slogan 
“Intelligent Ventilation”.  
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These advances raise the question as to whether INVENT has been superseded? Once again the 
answer is probably not. Systems such as SmartCare and ASV are focused on the less challenging 
patients balancing the speed of weaning against the CO2 level and potential exhaustion of the 
patient. Unlike INVENT they do not consider the appropriate balance of high or low volume 
strategy or FIO2 level. In addition the lack of models in these systems means that they do not 
learn about the patient during the process of management. Changes in pressure support and the 
resulting CO2 and ventilation profile ought to be sufficient to parameterize the patient’s response 
and learn about their net respiratory drive. In this respect the recent developments in neurological 
adjusted ventilation (Neurally adjusted ventilator assist (NAVA)) are very exciting [116]. In the 
NAVA system the electrical activity of the diagphram is measured on a breath by breath basis, 
and the pressure support delivered to the patient is then proportional to this activity. In doing so 
the system aims to ensure synchronization between the ventilator and the patient, and that most 
support is provided to the patient when demand is greatest. A clinically adjusted gain factor is set 
as the proportionality constant between the electrical signal and the average support delivered.  
This gain factor can be seen to represent two different aspects. It can be used to represent a 
parameterization of the net respiratory drive, including the muscular, neurological, and chemical 
control components. As such it may well reflect changes in the patient’s state over time and be a 
useful monitoring parameter, with a lower gain meaning a lower average support necessary for 
the same electrical activity. However, it also represents the clinician’s preference toward high or 
low volume ventilation strategy with different values of the gain effectively selecting different 
balance points of the compromise between the risks of baro/volu-trauma and acidosis/alkalosis. 
The major assumption underlying the use of NAVA is that variability in support on a breath by 
breath basis adjusted according to diaphragm activity and clinical selection of the gain factor 
improves patient care. Clinical studies applying NAVA in critically ill patients are only now 
beginning to be published [117], and whether this presents a real improvement in patient care 
remains unknown.    
The further success of INVENT depends upon a number of factors. INVENT III requires 
prospective evaluation. For development of INVENT V, models are required which adequately 
describe the effects of PEEP and inspiratory:expiratory ratio, and models are required of the 
various components of respiratory drive if INVENT is to be used in support modes. Work is 
currently underway in all these aspects, with some promising results [118, 119]. Probably the 
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most important factor is collaboration with an industrial partner. Eventual success of the system 
requires integration with standard ventilators enabling closed loop control of ventilator settings.  
 
5.4 Conclusions 
This dissertation has addressed the broad hypothesis as to whether building mathematical models 
is useful. In doing so it has illustrated a further example of the role of modeling in describing and 
understanding complex systems. The dissertation has shown that when dealing with complexity 
the goal of the model must be in focus if a correct balance is to be maintained between system 
complexity and model parameterization. 
The original goal of the INVENT team, i.e. to build, evaluate and integrate a DSS for control of 
mechanical ventilation has not as yet been completed. However the broader hypothesis that 
building models generates new and interesting questions has been successfully demonstrated. 
The ALPE model and system has been applied in ICU, post operative care and cardiology and is 
currently being applied in new clinical domains. ARTY has been shown to have potential benefit 
in eliminating the need for painful arterial punctures, and may also be useful as a screening tool. 
These systems illustrate the benefits of investing in models as a mechanism for transferring 
scientific knowledge to clinical practice.   
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7. Summary  
This dissertation has addressed the broad hypothesis as to whether building mathematical models 
is useful as a tool for translating physiological knowledge into clinical practice. In doing so it 
describes work on the INtelligent VENTilator project (INVENT), the goal of which is to build, 
evaluate and integrate into clinical practice, a model-based decision support system for control of 
mechanical ventilation. The dissertation describes the mathematical models included in 
INVENT, i.e. a model of pulmonary gas exchange focusing on oxygen transport, and a model of 
the acid-base status of blood, interstitial fluid and tissues. These models have been validated, and 
applied in two other systems: ALPE, a system for measuring pulmonary gas exchange and 
ARTY, a system for arterialisation of the acid-base and oxygen status of peripheral venous 
blood.  
The major contributions of this work are as follows. A mathematical model has been developed 
which can describe pulmonary gas exchange more accurately that current clinical techniques. 
This model is parsimonious in that it can describe pulmonary gas exchange from measurements 
easily available in the clinic, along with a readily automatable variation in FIO2. This technique 
and model have been developed into a research and commercial tool (ALPE), and evaluated both 
in the clinical setting and when compared to the reference multiple inert gas elimination 
technique (MIGET).  
Mathematical models have been developed of the acid-base chemistry of blood, interstitial fluid 
and tissues, with these models formulated using a mass-action mass-balance approach. The 
model of blood has been validated against literature data describing the addition and removal of 
CO2, strong acid or base, and haemoglobin; and the effects of oxygenation or deoxygenation. 
The model has also been validated in new studies, and shown to simulate accurately and 
precisely the mixing of blood samples at different PCO2 and PO2 levels. This model of acid-base 
chemistry of blood has been applied in the ARTY system. ARTY has been shown to accurately 
and precisely calculate arterial values of acid-base and oxygen status in patients residing in the 
ICU, and in those with chronic lung disease.  
The INtelligent VENTilator (INVENT) system has been developed for optimization of 
mechanical ventilator settings using physiological models and utility/penalty functions, 
separating physiological knowledge from clinical preference. The models can be tuned to the 
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individual patient via parameter estimation, providing patient specific advice. The INVENT team 
has shown prospectively that the system provides advice on FIO2 which is as good as clinical 
practice, and retrospectively that the system provides reasonable suggestions of tidal volume, 
respiratory frequency and FIO2.  
In general, this dissertation has illustrated a further example of the role of modeling in describing 
and understanding complex systems. The dissertation has shown that when dealing with 
complexity the goal of the model must be in focus if a correct balance is to be maintained 
between system complexity and model parameterization. The original goal of the INVENT team, 
i.e. to build, evaluate and integrate a DSS for control of mechanical ventilation has not as yet 
been completed. However, the broader hypothesis that building models generates new and 
interesting questions has been successfully demonstrated. The ALPE model and system has been 
applied in intensive care, post operative care and cardiology and is currently being evaluated in 
new clinical domains. ARTY has been shown to have potential benefit in eliminating the need 
for painful arterial punctures, and may also be useful as a screening tool. These systems illustrate 
the benefits of investing in models as a mechanism for translating physiological knowledge to 
clinical practice.   
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8. Dansk Resumé 
Denne afhandling har søgt at besvare den brede hypotese om, hvorvidt det at bygge matematiske 
modeller er et brugbart værktøj til at omsætte fysiologisk viden til klinisk praksis. Herunder 
beskriver afhandlingen arbejdet med INtelligent VENTilator projektet (INVENT), som har det 
mål at bygge, evaluere og integrere et modelbaseret medicinsk beslutningsstøttesystem til kontrol 
af mekanisk ventilation i klinisk praksis. Afhandlingen beskriver de matematiske modeller der 
indgår i INVENT, dvs. en model af den pulmonale gasudveksling med fokus på ilttransport og 
en model af syre-base status i blodet, den interstitielle væske samt vævene. Disse modeller er 
blevet valideret, og anvendt i to andre systemer: ALPE som er et system til at måle pulmonal 
gasudveksling, og ARTY som er et system til at udregne udregne arteriel syre-base og ilt status 
ud fra perifer venøs blod. 
De primære bidrag fra dette arbejde er som følger. En matematisk model er blevet udviklet som 
kan beskrive pulmonal gasudveksling mere nøjagtigt in nuværende kliniske målemetoder. Denne 
model er ”parsimonious”, idet den kan beskrive pulmonal gasudveksling ud fra målinger som er 
let tilgængelige i klinisk praksis sammen med en variation i FIO2, som let kan automatiseres. 
Denne målemetode og model er blevet udviklet til et forsknings- og kommercielt værktøj 
(ALPE), og er blevet evalueret både klinisk og i sammenligning med referencemetoden, ”the 
multiple inert gas elimination technique” (MIGET). 
Matematiske modeller af syre-base kemien i blod, interstitiel væske samt vævene er blevet 
udviklet ud fra massevirkning og massebevarelse principper. Modellen af blodet er blevet 
valideret mod data fra litteraturen, som beskriver tilførelse og fjernelse af CO2, stærk syre eller 
base, og hæmoglobin samt effekterne af oxidation. Modellen er også blevet valideret i nye 
studier, som har vist at modellen nøagtigt og præcist kan simulere blanding af blod med 
forskellige PCO2 og PO2 niveauer. Denne model af blodets syre-base kemi er blevet anvendt i 
ARTY systemet. Det er blevet vist at ARTY nøjagtigt og præcist kan udregne arterielle værdier 
for syre-base og oxygen status i patienter på en intensivafdeling, og i patienter med kronisk 
lungesygdom. 
INtelligent VENTilator (INVENT) systemet er blevet udviklet til optimering af 
respiratorindstillinger ved at bruge fysiologiske modeller og nytte/straf-funktioner, hvorved 
fysiologisk viden adskilles fra kliniske præferencer. Modellerne kan tilpasses den individuelle 
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patient via parameterestimering, for derved at muliggøre patient specfikke råd. INVENT holdet 
har vist i et prospektivt studie at systemets råd om indstilling af FIO2 er lige så hensigtsmæssige 
som niveauer valgt i klinisk praksis og i et retrospektivt studie at systemet giver fornuftige råd 
om indstilling af tidalvolumen, respirationsfrekvens og FIO2. 
Generelt set har denne afhandling illustreret et yderligere eksempel på modellerings rolle i 
forbindelse med beskrivelse og forståelse af komplekse systemer. Afhandlingen har vist at ved 
arbejde med kompleksitet det nødvendigt at bevare fokus på modellens mål, hvis man skal 
opretholde den korrekte balance imellem kompleksitet af systemet og parametrisering af 
modellen. Det oprindelige mål for INVENT holdet om at bygge, evaluere og integrere et 
beslutningsstøttesystem til kontrol af mekanisk ventilation er endnu ikke blevet opnået. Trods 
det, så er den bredere hypotese om, at det at bygge modeller genererer nye og interessante 
spørgsmål, blevet succesfuldt demonstreret. ALPE modellen og systemet er blevet anvendt i 
intensiv medicin, postoperativ pleje samt kardiologi og bliver i øjeblikket evalueret i nye kliniske 
domæner. Det er blevet vist, at ARTY potentielt kan gøre gavn ved at fjerne behovet for 
smertefulde arterielle punkturer og at det kan være et nyttigt værktøj til screening. Disse 
systemer illustrerer fordelene ved at investere i modeller som en meknisme til at omsætte 
fysiologisk viden til klinisk praksis.  
 
 
